Praxis Precision Medicines Inc (NAS:PRAX)
$ 77.495 0.245 (0.32%) Market Cap: 1.44 Bil Enterprise Value: 1.08 Bil PE Ratio: 0 PB Ratio: 3.59 GF Score: 37/100

Praxis Precision Medicines Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 09:00PM GMT
Release Date Price: $131.25 (-4.99%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Great. Good afternoon, everybody. Welcome back to the Bank of America Healthcare Conference day 2. I am Tazeen Ahmad. I'm one of the senior SMID biotech analysts here at the bank. It's my pleasure to have our next presenting company with us, Praxis Precision Medicines. Sitting next to me are Marcio Souza, who's President and CEO; as well as Bernard Ravina, who is the Chief Medical Officer. Gentlemen, good afternoon, and thank you for coming to Las Vegas.

Marcio Souza
Praxis Precision Medicines, Inc. - President, CEO & Director

Thank you. Thanks for having us.

Tazeen Ahmad;Marcio Souza
BofA Securities, Research Division - MD in Equity Research & Research Analyst;Praxis Precision

So maybe, Marcio, can we start with a quick overview of the company, maybe a 2-minute summary of your platform and some of the recent developments, and then we can go into some more detailed questions?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot